# Effect of Nitric Oxide in Cardiac Surgery Patients With Endothelial Dysfunction.

> **NCT02836899** · PHASE3 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 250 (actual)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** Nitric Oxide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02836899
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-08
- **Primary completion:** 2025-08-15
- **Final completion:** 2025-08-15
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2026-03-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02836899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02836899, "Effect of Nitric Oxide in Cardiac Surgery Patients With Endothelial Dysfunction.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02836899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*